mTOR-IN-1 - CAS# 1207358-59-5 Catalog No.:M9817-2 which may result in the

which may result in the inhibition of DNA replication and mitosis

The affinity (Kd) for the dopamine D1 and D2 receptors during withdrawal from acute and chronic administration of reserpine is not change[1]

31)15-17-7-5-4-6-8-17/h4-8

IWR-1 inhibits cell proliferation and EMT even in the presence of TNF-α-induced cancer cell stimulation

mTOR-IN-1 - CAS# 1207358-59-5 Catalog No.:M9817-2 which may result in themTOR IN 1 is a remarkably selective mTOR inhibitor with a Ki of 1. 5 nM. mTOR IN 1 suppresses mTORC1 and mTORC2 in cellular and in vivo pharmacokinetic (PK) pharmacodynamic (PD) experiments. In Vitro: mTOR IN 1 (Compound 12i) inhibits mTOR with a Ki of 1. 5 nM, 500 fold selectivity over closely related PI3 kinases. mTOR IN 1 inhibits NCI PC3 and MCF7neo Her2 cells proliferation with IC50s of 150 nM and 57 nM, respectively[2]. In Vivo: mTOR IN 1